Cargando…
ITIH4: A New Potential Biomarker of “Toxin Syndrome” in Coronary Heart Disease Patient Identified with Proteomic Method
Objective. This trial aims to look for the protein biomarker of “toxin syndrome” of CHD patients. Methods. We have performed two trials in this paper. The first trial was a randomized controlled trial (RCT) of the plasma proteome in unstable angina (UA) patients by Maldi-Tof Mass. The second trial w...
Autores principales: | Xu, Hao, Shang, Qinghua, Chen, Hao, Du, Jianpeng, Wen, Jianyan, Li, Geng, Shi, Dazhuo, Chen, Keji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760120/ https://www.ncbi.nlm.nih.gov/pubmed/24023573 http://dx.doi.org/10.1155/2013/360149 |
Ejemplares similares
-
Complex Networks Approach for Analyzing the Correlation of Traditional Chinese Medicine Syndrome Evolvement and Cardiovascular Events in Patients with Stable Coronary Heart Disease
por: Gao, Zhuye, et al.
Publicado: (2015) -
Inhibition of vascular remodelling in a porcine coronary injury model by herbal extract XS0601
por: Xu, Hao, et al.
Publicado: (2006) -
miR-941 as a promising biomarker for acute coronary syndrome
por: Bai, Ruina, et al.
Publicado: (2017) -
Oral Panax notoginseng Preparation for Coronary Heart Disease: A Systematic Review of Randomized Controlled Trials
por: Shang, Qinghua, et al.
Publicado: (2013) -
Atherosclerosis: An Integrative East-West Medicine Perspective
por: Xu, Hao, et al.
Publicado: (2012)